Abstract：Objective To evaluate vaccine efficacy(VE) of Haemophilus influenza type b vaccine (Hib) among children under five years of age . Methods Searching “National Center for Biotechnology Information, NCBI”,“Cochrane Library,CL”,“China Biology Medicine disc, CBMd”,“China National Knowledge Infrastructure, CNKI”,“ Wanfang Database, the studies of VE for Hib among children under five years of age were included, and meta-analysis were made by RevMan 5.3 software. Results A total of 9 studies were included, seven were randomised clinical trial(RCT) design and two were semi RCT design. The VEs of one dose, two doses and three doses of Hib were 65%(95%CI23%-84%), 79%(95%CI 54%-90%), and 85%(95%CI 77%-90%), respectively. Conclusion We found that Hib is highly effective and that the two dose regime is as good as the three dose regime.
胡昱, 李倩, 张兵, 陈雅萍. 5岁以下儿童接种b型流感嗜血杆菌疫苗流行病学效果的Meta分析[J]. 预防医学, 2016, 28(12): 1208-1213.
HU Yu,LI Qian,ZHANG Bing,CHEN Ya-ping. A meta-analysis of vaccine efficacy of haemophilus influenza type b vaccine among children under five years of age. Preventive Medicine, 2016, 28(12): 1208-1213.
[1]钱晓华,王传清,朱启镕,等.社区儿童接种b型流行性感冒嗜血杆菌结合疫苗的前瞻性队列研究[J].中国疫苗和免疫,2010,16(2):157-160. [2]WHO. Global and regional immunization profile [EB/OL].[2011-12-01]http://www.who.int/immunization_monitoring/en/globalsummary/GS_GLOProfilepdf. [3]朱启镕, 杨永弘, 刁连东. 中国b 型流感嗜血杆菌疾病及其免疫预防研讨会会议纪要[J].中华传染病杂志,2005,23(6):434-435. [4]ESKOLA J, KYHTY H, TAKALA A K, et al. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease[J]. New England Journal of Medicine, 1990, 323(20):1381-1387. [5]LAGOS R, HORWITZ I, TORO J, et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.[J]. Pediatric Infectious Disease Journal, 1996, 15(3):216-222. [6]MULHOLLAND K, HILTON S, ADEGBOLA R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants[J]. Lancet, 1997, 349(9060):1191-1197. [7]SANTOSHAM M, WOLFF M, REID R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex[J]. New England Journal of Medicine, 1991, 324(25): 1767-1772. [8]WARD J, BRENNEMAN G, LETSON G W, et al. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska native infants[J]. New England Journal of Medicine, 1990, 323(20): 1393-1401. [9]BLACK S B, SHINEFIELD H R, FIREMAN B, et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children[J]. The Pediatric infectious disease journal, 1991, 10(2): 97-103. [10]BOOY R, HODGSON S, MOXON E R, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T[J]. The Lancet, 1994, 344(8919): 362-366. [11]VADHEIM C M, GREENBERG D P, PARTRIDGE S, et al. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants[J]. Pediatrics, 1993, 92(2): 272-279. [12]GESSNER B D, SUTANTO A, LINEHAN M, et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial[J]. The Lancet, 2005, 365(9453): 43-52. [13]FITZWATER S P, WATT J P, LEVINE O S, et al. Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries[J]. Human vaccines, 2010, 6(10): 810-818. [14]GRIFFITHS U K, CLARK A, GESSNER B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials[J]. Epidemiology & Infection, 2012, 140(8):1343-1355. [15]O'LOUGHLIN R E, EDMOND K, MANGTANI P, et al. Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review[J]. European Heart Journal Acute Cardiovascular Care, 2010, 28(38):6128-6136. [16]JACKSON C, MANN A, MANGTANI P, et al. Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data[J]. The Pediatric Infectious Disease Journal, 2013, 32(11): 1261-1269.
